Component

RA concentration in sampled human CSF

RA concentration in sampled human CSF

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. RA was below the stated CSF detection limit at the sampled trial visits.

    Experimental context and source evidence
    evidence_access
    Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
    experimental_model
    Baseline and week 24; sampling generally 4–5 h after capsules; limit 0.0028 nM.
    interpretation_status
    Recorded from source with stated access limits; ungraded, not independent replication.
    limitations
    Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
    nutrient_topic
    Rosmarinic acid collection; exact intervention and molecular form govern interpretation. · Rosmarinic acid
    plain_language
    RA was below the stated CSF detection limit at the sampled trial visits.
    primary_references
    Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression. | https://pubmed.ncbi.nlm.nih.gov/33122694/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC7596544/ | https://doi.org/10.1038/s41598-020-73729-2
    source_locator
    Reviewed reference ra-csf-detection; A negative sampled concentration is not proof of absent exposure at all earlier times.

    Rosmarinic acid: detailed mechanisms of action (reviewed 10 October 2026) · lines 465–471

    AI-assisted original curation of primary studies; claim-local access and experimental limitations stated. Includes original-draft correction history. No independent replication claimed. · supports · Baseline and week 24; sampling generally 4–5 h after capsules; limit 0.0028 nM. · Recorded from source · Recorded from source

    ### ra-csf-detection RA was below the stated CSF detection limit at the sampled trial visits. A negative sampled concentration is not proof of absent exposure at all earlier times. Model and exposure: Baseline and week 24; sampling generally 4–5 h after capsules; limit 0.0028 nM. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression. | 2020 | https://pubmed.ncbi.nlm.nih.gov/33122694/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC7596544/ | https://doi.org/10.1038/s41598-020-73729-2 | Access: Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.